Unknown

Dataset Information

0

Fourth-generation chimeric antigen receptor T-cell therapy is tolerable and efficacious in treatment-resistant rheumatoid arthritis.

ABSTRACT:

SUBMITTER: Li Y 

PROVIDER: S-EPMC11909189 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Fourth-generation chimeric antigen receptor T-cell therapy is tolerable and efficacious in treatment-resistant rheumatoid arthritis.

Li Yujing Y   Li Sujun S   Zhao Xiaojuan X   Sheng Jun J   Xue Lei L   Schett Georg G   Shi Ce C   Hu Biliang B   Wang Xingbing X   Chen Zhu Z  

Cell research 20250109 3

Similar Datasets

Unknown Generation of hypoxia-sensing chimeric antigen receptor T cells.
| S-EPMC8353489 | biostudies-literature
Unknown Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas.
| S-EPMC7731732 | biostudies-literature
Unknown Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells.
| S-EPMC5363191 | biostudies-literature
Unknown Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf.
| S-EPMC5699508 | biostudies-literature
Unknown Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumors.
| S-EPMC11574131 | biostudies-literature
Unknown Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity.
| S-EPMC6701025 | biostudies-literature
Unknown The Next Generation of Cellular Immunotherapy: Chimeric Antigen Receptor-Natural Killer Cells.
| S-EPMC9547868 | biostudies-literature
Unknown Optimal Chimeric Antigen Receptor (CAR)-mRNA for Transient CAR T Cell Generation.
| S-EPMC11818003 | biostudies-literature
Unknown Chimeric antigen receptor-macrophages: Emerging next-generation cell therapy for brain cancer.
| S-EPMC12080554 | biostudies-literature
Unknown Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer.
| S-EPMC8833489 | biostudies-literature